New drug duo tested for Hard-to-Treat blood cancer

NCT ID NCT04246086

Recruiting now Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

Summary

This study is testing the safety and effectiveness of combining two drugs, mosunetuzumab and lenalidomide, for people with follicular lymphoma, a type of blood cancer. It will involve about 237 participants who have either tried previous treatments or are newly diagnosed but need therapy. The research will also compare giving one drug as an injection under the skin versus through an IV drip.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHRU de Lille - Hopital Claude Huriez
WITHDRAWN

Lille, 59037, France
CHU Montpellier
WITHDRAWN

Montpellier, 34295, France
CHU Rennes - Hopital Pontchaillou
ACTIVE_NOT_RECRUITING

Rennes, 35033, France
Centre Hospitalier Lyon Sud
ACTIVE_NOT_RECRUITING

Pierre-Bénite, 69495, France
City of Hope National Medical Center
RECRUITING

Duarte, California, 91010, United States
Cleveland Clinic
RECRUITING

Cleveland, Ohio, 44195-0001, United States
Complejo Asistencial Universitario de Salamanca
WITHDRAWN

Salamanca, 37007, Spain
Duke University Medical Center
RECRUITING

Durham, North Carolina, 27710-4000, United States
Fairview Hospital
RECRUITING

Cleveland, Ohio, 44111, United States
Freeman Hospital
COMPLETED

Newcastle upon Tyne, NE7 7DN, United Kingdom
Fudan University Shanghai Cancer Center
RECRUITING

Shanghai, 200120, China
Hillcrest Hospital
RECRUITING

Mayfield Heights, Ohio, 44124, United States
Hospital Universitario Fundacion Jimenez Diaz.
ACTIVE_NOT_RECRUITING

Madrid, 28040, Spain
Hospital Universitario Vall d Hebron
WITHDRAWN

Barcelona, 08035, Spain
Hospital Universitario Virgen de la Victoria
ACTIVE_NOT_RECRUITING

Málaga, 29010, Spain
Hunan Cancer Hospital
WITHDRAWN

Changsha, 410013, China
Hôpital Saint-Louis
WITHDRAWN

Paris, 75475, France
Institut Claudius Regaud
WITHDRAWN

Toulouse, 31059, France
Mary Bird Perkins Cancer Ctr
RECRUITING

Baton Rouge, Louisiana, 70809, United States
Norton Cancer Institute - St. Matthews
RECRUITING

Louisville, Kentucky, 40207-4723, United States
Nottingham University Hospitals NHS Trust - City Hospital
ACTIVE_NOT_RECRUITING

Nottingham, NG5 1PB, United Kingdom
Oxford University Hospitals NHS Foundation Trust
WITHDRAWN

Oxford, OX3 7LE, United Kingdom
Rhode Island Hematology/Oncology Program
RECRUITING

Woonsocket, Rhode Island, 02895-4720, United States
Swedish Medical Center
RECRUITING

Seattle, Washington, 98122, United States
Tennessee Oncology PLLC - Franklin
RECRUITING

Franklin, Tennessee, 37067, United States
Tennessee Oncology;Chattanooga Oncology & Hematology Associates
RECRUITING

Chattanooga, Tennessee, 37404, United States
The Christie NHS Foundation Trust
ACTIVE_NOT_RECRUITING

Manchester, M20 4BX, United Kingdom
The First Affiliated Hospital of Xiamen University
RECRUITING

Xiamen, 361003, China
The First Hospital of Jilin University
RECRUITING

Changchun, 130021, China
Tianjin Medical University Cancer Institute & Hospital
RECRUITING

Tianjing, 300060, China
University College London Hospitals NHS Foundation Trust - University College Hospital
ACTIVE_NOT_RECRUITING

London, NW1 2PG, United Kingdom
University of Miami Miller School of Medicine
RECRUITING

Miami, Florida, 33136-1002, United States
University of Michigan Comprehensive Cancer Center
RECRUITING

Ann Arbor, Michigan, 48109, United States
West China Hospital, Sichuan University
RECRUITING

Chengdu, 610041, China

Conditions

Explore the condition pages connected to this study.

FOLLICULAR LYMPHOMA